PF-Atlas › Clinical Trials › NCT05315557

Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial

Terlipressin · Not specified

Registry ID

NCT05315557

Phase

Not specified

Status

Unknown

Drug / intervention

Terlipressin

Sponsor

Institute of Liver and Biliary Sciences, India

Start

2022-04-05

About this trial

Terlipressin is evaluated in NCT05315557, a idiopathic pulmonary fibrosis study sponsored by Institute of Liver and Biliary Sciences, India. Current status: Unknown.

View NCT05315557 on ClinicalTrials.gov →

Explore related

All Terlipressin trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT05315557 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.